232 related articles for article (PubMed ID: 18329082)
1. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.
Choi M; Fuller CD; Thomas CR; Wang SJ
Gynecol Oncol; 2008 May; 109(2):203-9. PubMed ID: 18329082
[TBL] [Abstract][Full Text] [Related]
2. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998.
Fuller CD; Wang SJ; Thomas CR; Hoffman HT; Weber RS; Rosenthal DI
Cancer; 2007 Apr; 109(7):1331-43. PubMed ID: 17326199
[TBL] [Abstract][Full Text] [Related]
3. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
4. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
5. Relative lack of conditional survival improvement in young adults with cancer.
Bleyer A; Choi M; Fuller CD; Thomas CR; Wang SJ
Semin Oncol; 2009 Oct; 36(5):460-7. PubMed ID: 19835741
[TBL] [Abstract][Full Text] [Related]
6. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
7. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
8. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
[TBL] [Abstract][Full Text] [Related]
9. Survival among U.S. women with invasive epithelial ovarian cancer.
McGuire V; Jesser CA; Whittemore AS
Gynecol Oncol; 2002 Mar; 84(3):399-403. PubMed ID: 11855877
[TBL] [Abstract][Full Text] [Related]
10. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.
Davis FG; McCarthy BJ; Freels S; Kupelian V; Bondy ML
Cancer; 1999 Jan; 85(2):485-91. PubMed ID: 10023719
[TBL] [Abstract][Full Text] [Related]
11. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.
Wethington SL; Herzog TJ; Seshan VE; Bansal N; Schiff PB; Burke WM; Cohen CJ; Wright JD
Cancer; 2008 Dec; 113(12):3298-306. PubMed ID: 19006196
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation.
Punyko JA; Mertens AC; Baker KS; Ness KK; Robison LL; Gurney JG
Cancer; 2005 Apr; 103(7):1475-83. PubMed ID: 15712283
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of women with metachronous breast and ovarian carcinomas.
Liou WS; Hamilton CA; Cheung MK; Osann K; Longacre TA; Teng NN; Husain A; Dirbas FM; Chan JK
Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424
[TBL] [Abstract][Full Text] [Related]
15. 5- and 10-year survival in cancer patients aged 90 and older: a study of 37,318 patients from SEER.
Saltzstein SL; Behling CA
J Surg Oncol; 2002 Nov; 81(3):113-6; dicussion 117. PubMed ID: 12407720
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 91 cases of hereditary breast and ovarian cancer].
Li N; Wu LY; Zhang R; Zhang X; Liu LY
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):245-7. PubMed ID: 15949430
[TBL] [Abstract][Full Text] [Related]
17. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
Jani AB; Johnstone PA; Liauw SL; Master VA; Brawley OW
Am J Clin Oncol; 2008 Aug; 31(4):375-8. PubMed ID: 18845997
[TBL] [Abstract][Full Text] [Related]
18. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers.
Janssen-Heijnen ML; Gondos A; Bray F; Hakulinen T; Brewster DH; Brenner H; Coebergh JW
J Clin Oncol; 2010 May; 28(15):2520-8. PubMed ID: 20406936
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.
Roman S; Lin R; Sosa JA
Cancer; 2006 Nov; 107(9):2134-42. PubMed ID: 17019736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
